Obinutuzumab for the First-Line Treatment of Follicular Lymphoma | NobleBlocks

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

Public

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

N

Shared by NobleBlocks on Oct 5, 2017 • 12:00 AM UTC

Authors:

Robert Marcus

,

Andrew Davies

,

Kiyoshi Ando

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Oct 5, 2017 • 12:00 AM UTC

NobleID:w1/20260526/FF138F82

DOI:10.1056/nejmoa1614598

No figures available

Scan for Errors

Scan for EDDII

Summarise

Generate Podcast